Full text biomedical articles

Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids

Fabrizio Spada, Tanya M Barnes, Kerryn A Greive
Australas J Dermatol. 2018 Aug; 59(3): e168–e174. Published online 2018 Feb 7. doi: 10.1111/ajd.12762


Article   |   PubReader   |   PDF–160K   |   Cite

Comparison of the Efficacy, Side Effects, and Cost of Modafinil and Intranasal Mometasone Furoate in Obstructive Sleep Apnea-Hypopnea Syndrome: A Preliminary Clinical Study

Shujia Zhang, Jing Fu, Zhongnin Duan
Med Sci Monit. 2018; 24: 3084–3092. Published online 2018 May 11. doi: 10.12659/MSM.907565


Article   |   PubReader   |   PDF–420K   |   Cite

The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression

Ingrid T. G. W. Bijsmans, Chiara Guercini, José M. Ramos Pittol, Wienand Omta, Alexandra Milona, Daphne Lelieveld, David A. Egan, Roberto Pellicciari, Antimo Gioiello, Saskia W. C. van Mil
Sci Rep. 2015; 5: 14086. Published online 2015 Sep 15. doi: 10.1038/srep14086


Article   |   PubReader   |   PDF–1.3M   |   Cite

Significant receptor affinities of metabolites and a degradation product of mometasone furoate

Anagnostis Valotis, Petra Högger
Respir Res. 2004; 5(1): 7. Published online 2004 Jul 22. doi: 10.1186/1465-9921-5-7


Article   |   PubReader   |   PDF–255K   |   Cite

Interventions for hand eczema

Wietske Andrea Christoffers, Pieter‐Jan Coenraads, Åke Svensson, Thomas L Diepgen, Janine L Dickinson‐Blok, Jun Xia, Hywel C Williams, Cochrane Skin Group
Cochrane Database Syst Rev. 2019 Apr; 2019(4): CD004055. Published online 2019 Apr 26. doi: 10.1002/14651858.CD004055.pub2


Article   |   PubReader   |   PDF–2.6M   |   Cite

Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate

Zia R Tayab, Tom C Fardon, Daniel K C Lee, Kay Haggart, Lesley C McFarlane, Brian J Lipworth, Günther Hochhaus
Br J Clin Pharmacol. 2007 Nov; 64(5): 698–705. Published online 2007 May 17. doi: 10.1111/j.1365-2125.2007.02919.x


Article   |   PubReader   |   PDF–176K   |   Cite

Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas

Yao Liao, Gang Feng, Tangzhi Dai, Fengjiao Long, Junfei Tang, Yuanxue Pu, Xuhai Zheng, Sui Cao, Shan Xu, Xiaobo Du
Medicine (Baltimore) 2019 Dec; 98(52): e18230. Published online 2019 Dec 27. doi: 10.1097/MD.0000000000018230


Article   |   PubReader   |   PDF–565K   |   Cite

In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis

J. Pablo Stolovitzky, Robert C. Kern, Joseph K. Han, Keith D. Forwith, Randall A. Ow, Simon K. Wright, Andrew Gould, Keith E. Matheny, Boris Karanfilov, Saling Huang, James W. Stambaugh, Anna K. Gawlicka
Am J Rhinol Allergy. 2019 Sep; 33(5): 545–558. Published online 2019 May 23. doi: 10.1177/1945892419850924


Article   |   PubReader   |   PDF–1.6M   |   Cite

Cost-Effectiveness Analysis of Mometasone Furoate Versus Beclomethasone Dipropionate for the Treatment of Pediatric Allergic Rhinitis in Colombia

Carlos E. Rodríguez-Martínez, Monica P. Sossa-Briceño, Elkin Vladimir Lemos
Adv Ther. 2015; 32(3): 254–269. Published online 2015 Mar 10. doi: 10.1007/s12325-015-0192-6


Article   |   PubReader   |   PDF–710K   |   Cite

A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps

Robert C. Kern, J. Pablo Stolovitzky, Stacey L. Silvers, Ameet Singh, Jivianne T. Lee, David M. Yen, Alfred M.C. Iloreta, Jr., Francis P.J. Langford, Boris Karanfilov, Keith E. Matheny, James W. Stambaugh, Anna K. Gawlicka, for the RESOLVE II study investigators
Int Forum Allergy Rhinol. 2018 Apr; 8(4): 471–481. Published online 2018 Jan 19. doi: 10.1002/alr.22084


Article   |   PubReader   |   PDF–548K   |   Cite


Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

David Price, Anne Robertson, Kevin Bullen, Cynthia Rand, Rob Horne, Heribert Staudinger
BMC Pulm Med. 2010; 10: 1. Published online 2010 Jan 5. doi: 10.1186/1471-2466-10-1


Article   |   PubReader   |   PDF–560K   |   Cite

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

Teddy Kosoglou, James Hubbell, Fengjuan Xuan, David L Cutler, Alan G Meehan, Bhavna Kantesaria, Bret A Wittmer
Int J Chron Obstruct Pulmon Dis. 2013; 8: 107–116. Published online 2013 Mar 4. doi: 10.2147/COPD.S36592


Article   |   PubReader   |   PDF–455K   |   Cite

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

Michael Noonan, Jeffrey Leflein, Jonathan Corren, Heribert Staudinger
BMC Pediatr. 2009; 9: 43. Published online 2009 Jul 13. doi: 10.1186/1471-2431-9-43


Article   |   PubReader   |   PDF–252K   |   Cite

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

Dennis E Doherty, Donald P Tashkin, Edward Kerwin, Barbara A Knorr, Tulin Shekar, Sibabrata Banerjee, Heribert Staudinger
Int J Chron Obstruct Pulmon Dis. 2012; 7: 57–71. Published online 2012 Feb 3. doi: 10.2147/COPD.S27320


Article   |   PubReader   |   PDF–550K   |   Cite

Mometasone Absorption in Cultured Airway Epithelium

Tuong T. Nguyen, Paul S. Soma, Teresa Mascenik, Catherine A. Lewis, Rhianna E. Lee, Brian D. Thorp, Adam M. Zanation, Charles S. Ebert, Jr., Brent A. Senior, Scott H. Randell, Brandie M. Ehrmann, Adam J. Kimple
Int Forum Allergy Rhinol. Author manuscript; available in PMC 2020 Dec 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2019 Dec; 9(12): 1451–1455. Published online 2019 Oct 21. doi: 10.1002/alr.22441


Article   |   PubReader   |   PDF–594K   |   Cite

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase 3 Double-Blind, Randomized Trial from the North Central Cancer Treatment Group N06C4

Robert C. Miller, David J. Schwartz, Jeff A. Sloan, Patricia C. Griffin, Richard L. Deming, Jon C. Anders, Thomas J. Stoffel, Robert E. Haselow, Paul L. Schaefer, James D. Bearden, III, Pamela J. Atherton, Charles L. Loprinzi, James A. Martenson
Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2012 Apr 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5): 1460–1466. Published online 2010 Aug 26. doi: 10.1016/j.ijrobp.2010.01.031


Article   |   PubReader   |   PDF–368K   |   Cite

Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma

Jorge F Maspero, Hendrik Nolte, Iván Chérrez-Ojeda
J Asthma. 2010 Dec; 47(10): 1106–1115. Published online 2010 Sep 28. doi: 10.3109/02770903.2010.514634


Article   |   PubReader   |   PDF–1.2M   |   Cite

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects

Satoru Inoue, Soniya Vaidya, Hanns-Christian Tillmann, Yohei Sakita, Surendra Machineni, Olivier Heudi, Kenichi Furihata
BMC Pulm Med. 2021; 21: 18. Published online 2021 Jan 7. doi: 10.1186/s12890-020-01382-6


Article   |   PubReader   |   PDF–1.0M   |   Cite

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

Donald P Tashkin, Dennis E Doherty, Edward Kerwin, Carlos E Matiz-Bueno, Barbara Knorr, Tulin Shekar, Sibabrata Banerjee, Heribert Staudinger
Int J Chron Obstruct Pulmon Dis. 2012; 7: 43–55. Published online 2012 Feb 3. doi: 10.2147/COPD.S27319


Article   |   PubReader   |   PDF–347K   |   Cite